Market Cap (In EUR)
1.68 Million
Revenue (In EUR)
-
Net Income (In EUR)
-3.48 Million
Avg. Volume
33.3 Thousand
- Currency
- EUR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.05-0.664
- PE
- -
- EPS
- -
- Beta Value
- -0.475
- ISIN
- FI4000260583
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Juliusz Rakowskias
- Employee Count
- -
- Website
- https://www.bbs-artebone.fi
- Ipo Date
- 2018-02-28
- Details
- BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland. The company offers ARTEBONE, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins used primarily for the treatment of bone defects and healing problems in extremities, such as foot and ankle. BBS-Bioactive Bone Substitutes Plc was incorporated in 1991 and is headquartered in Oulu, Finland.
More Stocks
-
4346
-
FRW
-
YOOIFYANGAROO Inc.
YOOIF
-
CEROW
-
4DX
-
XWELXWELL, Inc.
XWEL
-
MANORAMAManorama Industries Limited
MANORAMA
-
TGRO